ArticleNucleic acid therapeutics2020

Bifunctional Aptamer-Doxorubicin Conjugate Crosses the Blood-Brain Barrier and Selectively Delivers Its Payload to EpCAM-Positive Tumor Cells.

Joanna Macdonald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.